Literature DB >> 19922520

Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives.

Paul Marques1, Scott Tippetts, John Allen, Martin Javors, Christer Alling, Michel Yegles, Fritz Pragst, Friedrich Wurst.   

Abstract

AIM: To identify alcohol biomarker and psychometric measures that relate to drivers' blood alcohol concentration (BAC) patterns from ignition interlock devices (IIDs). DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: In Alberta, Canada, 534 drivers, convicted of driving under the influence of alcohol (DUI), installed IIDs and agreed to participate in a research study. IID BAC tests are an established proxy for predicting future DUI convictions. Three risk groups were defined by rates of failed BAC tests. Program entry and follow-up blood samples (n = 302, 171) were used to measure phosphatidyl ethanol (PETH), carbohydrate deficient transferrin (%CDT), gamma glutamyltransferase (GGT) and other biomarkers. Program entry urine (n = 130) was analyzed for ethyl glucuronide (ETG) and ethyl sulphate (ETS). Entry hair samples were tested for fatty acid ethyl esters (FAEE) (n = 92) and ETG (n = 146). Psychometric measures included the DSM-4 Diagnostic Interview Schedule Alcohol Module, Alcohol Use Disorders Identification Test (AUDIT), the time-line follow-back (TLFB), the Drinker Inventory of Consequences (DRINC) and the Temptation and Restraint Inventory (TRI).
FINDINGS: Except for FAEE, all alcohol biomarkers were related significantly to the interlock BAC test profiles; higher marker levels predicted higher rates of interlock BAC test failures. PETH, the strongest with an overall analysis of variance F ratio of 35.5, had significant correlations with all nine of the other alcohol biomarkers and with 16 of 19 psychometric variables. Urine ETG and ETS were correlated strongly with the IID BAC tests.
CONCLUSIONS: The findings suggest that several alcohol biomarkers and assessments could play an important role in the prediction and control of driver alcohol risk when re-licensing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922520      PMCID: PMC2825139          DOI: 10.1111/j.1360-0443.2009.02738.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  36 in total

1.  PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.

Authors:  Steina Aradottir; Gulber Asanovska; Stefan Gjerss; Per Hansson; Christer Alling
Journal:  Alcohol Alcohol       Date:  2006-04-19       Impact factor: 2.826

2.  Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption.

Authors:  Anders Helander; Helen Dahl
Journal:  Clin Chem       Date:  2005-09       Impact factor: 8.327

3.  Primary and secondary prevention of drink driving by the use of alcolock device and program: Swedish experiences.

Authors:  Bo Bjerre
Journal:  Accid Anal Prev       Date:  2005-08-01

Review 4.  Effectiveness of ignition interlock devices in reducing drunk driving recidivism.

Authors:  J H Coben; G L Larkin
Journal:  Am J Prev Med       Date:  1999-01       Impact factor: 5.043

5.  Relationship between blood alcohol concentration and carbohydrate-deficient transferrin among drivers.

Authors:  Brice M R Appenzeller; Serge Schneider; Armand Maul; Robert Wennig
Journal:  Drug Alcohol Depend       Date:  2005-03-03       Impact factor: 4.492

6.  Heavy drinking among Norwegian male drunken drivers: a study of gamma-glutamyltransferase.

Authors:  H Gjerde; J Sakshaug; J Mørland
Journal:  Alcohol Clin Exp Res       Date:  1986 Mar-Apr       Impact factor: 3.455

7.  Forensic confirmatory analysis of ethyl sulfate--a new marker for alcohol consumption--by liquid-chromatography/electrospray ionization/tandem mass spectrometry.

Authors:  Sebastian Dresen; Wolfgang Weinmann; Friedrich Martin Wurst
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

8.  Determination of phosphatidylethanol in blood from alcoholic males using high-performance liquid chromatography and evaporative light scattering or electrospray mass spectrometric detection.

Authors:  T Gunnarsson; A Karlsson; P Hansson; G Johnson; C Alling; G Odham
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-02-13

9.  Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers.

Authors:  A Varga; P Hansson; C Lundqvist; C Alling
Journal:  Alcohol Clin Exp Res       Date:  1998-11       Impact factor: 3.455

10.  Formation of phosphatidylethanol in rat brain by phospholipase D.

Authors:  L Gustavsson; C Alling
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

View more
  22 in total

1.  Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems.

Authors:  Paul R Marques
Journal:  Drug Test Anal       Date:  2012-02-06       Impact factor: 3.345

2.  The effects of closer monitoring on driver compliance with interlock restrictions.

Authors:  Paul L Zador; Eileen M Ahlin; William J Rauch; Jan M Howard; G Doug Duncan
Journal:  Accid Anal Prev       Date:  2011-06-12

3.  Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.

Authors:  Donald M Dougherty; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Sharon E Cates; Sarah L Lake; Jillian Mullen; John D Roache
Journal:  Drug Alcohol Depend       Date:  2014-07-11       Impact factor: 4.492

4.  Accounting for sex-related differences in the estimation of breath alcohol concentrations using transdermal alcohol monitoring.

Authors:  Nathalie Hill-Kapturczak; John D Roache; Yuanyuan Liang; Tara E Karns; Sharon E Cates; Donald M Dougherty
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

5.  Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program.

Authors:  Paul Marques; Therese Hansson; Anders Isaksson; Lisa Walther; Joseph Jones; Douglas Lewis; Mary Jones
Journal:  Traffic Inj Prev       Date:  2011-04       Impact factor: 1.491

6.  Liquid Chromatography-Tandem Mass Spectrometry Assay to Detect Ethyl Glucuronide in Human Fingernail: Comparison to Hair and Gender Differences.

Authors:  Joseph Jones; Mary Jones; Charles Plate; Douglas Lewis; Michael Fendrich; Lisa Berger; Daniel Fuhrmann
Journal:  Am J Analyt Chem       Date:  2012-01-01

7.  Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.

Authors:  Martin A Javors; Nathalie Hill-Kapturczak; John D Roache; Tara E Karns-Wright; Donald M Dougherty
Journal:  Alcohol Clin Exp Res       Date:  2016-04-30       Impact factor: 3.455

8.  Mandating Treatment Based on Interlock Performance: Evidence for Effectiveness.

Authors:  Robert B Voas; A Scott Tippetts; Gwen Bergen; Milton Grosz; Paul Marques
Journal:  Alcohol Clin Exp Res       Date:  2016-07-18       Impact factor: 3.455

9.  Driver experiences with the alcohol ignition interlock: Comparing successful and poor performers.

Authors:  Kenneth H Beck; Michael Scherer; Eduardo Romano; Eileen Taylor; Robert Voas
Journal:  Traffic Inj Prev       Date:  2020-07-13       Impact factor: 1.491

10.  The impact of interlock installation on driving behavior and drinking behavior related to driving.

Authors:  Thomas H Nochajski; Amy R Manning; Robert Voas; Eileen P Taylor; Michael Scherer; Eduardo Romano
Journal:  Traffic Inj Prev       Date:  2020-08-12       Impact factor: 1.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.